Structure-activity relationships of alpha(IIb) 313-320 derived peptide inhibitors of human platelet aggregation
dc.contributor.author | Stanica, R. M. | en |
dc.contributor.author | Benaki, D. | en |
dc.contributor.author | Rodis, F. I. | en |
dc.contributor.author | Mikros, E. | en |
dc.contributor.author | Tsoukatos, D. | en |
dc.contributor.author | Tselepis, A. | en |
dc.contributor.author | Tsikaris, V. | en |
dc.date.accessioned | 2015-11-24T16:48:23Z | |
dc.date.available | 2015-11-24T16:48:23Z | |
dc.identifier.issn | 1075-2617 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/9313 | |
dc.rights | Default Licence | - |
dc.subject | alpha(iib) binding sites | en |
dc.subject | arginine interactions | en |
dc.subject | aspartic acid interactions | en |
dc.subject | fibrinogen inhibitors | en |
dc.subject | integrin alpha(iib)beta(3) | en |
dc.subject | nmr of peptides | en |
dc.subject | rgd conformation | en |
dc.subject | sars | en |
dc.subject | fibrinogen binding | en |
dc.subject | integrin alpha(iib)beta(3) | en |
dc.subject | thrombasthenia | en |
dc.subject | activation | en |
dc.subject | arginine | en |
dc.subject | conformations | en |
dc.subject | guanidinium | en |
dc.subject | gpiib/iiia | en |
dc.subject | receptor | en |
dc.subject | h-1-nmr | en |
dc.title | Structure-activity relationships of alpha(IIb) 313-320 derived peptide inhibitors of human platelet aggregation | en |
heal.abstract | The alpha(IIb)beta(3) receptor, which is the most abundant receptor on the surface of platelets, can interact with a variety of adhesive proteins including fibrinogen, fibronectin and the von Willebrand factor. Fibrinogen binding on alpha(IIb)beta(3) is an event essential for platelet aggregation and thrombus formation. Mapping of the fibrinogen-binding domains on alpha(IIb) subunit suggested the sequence 313-332 as a possible binding site. This region was restricted to sequence alpha(IIb) 313-320 (Y(313)MESRADR(320)) using synthetic octapeptides overlapping by six residues. The YMESRADR octapeptide inhibits ADP-stimulated human platelets aggregation and binds to immobilized fibrinogen. In this study, we used the Ala scanning methodology within the sequence 313-320 aiming to evaluate the contribution of each amino acid in inhibiting platelet aggregation. It was found that the substitution of Y-313, M-314, E-315 or S-316 by A does not affect the activity of the parent, octapeptide. The-RADR-motif seems to be the most essential for the biological activity of the all,, 313-320 site. The conformational analysis of the YAESRADR, YMESAADR and YMESRAAR analogs by using NMR spectroscopy and distance geometry calculations revealed significant differences in their conformational states. in DMSO-d(6). Copyright (C) 2008 European Peptide Society and John Wiley & Sons, Ltd. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | Doi 10.1002/Psc.1060 | - |
heal.identifier.secondary | <Go to ISI>://000260926800005 | - |
heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1002/psc.1060/asset/1060_ftp.pdf?v=1&t=h0f8951x&s=ec8ac62921f6af8dc5837b92e460abac77a7bdb9 | - |
heal.journalName | Journal of Peptide Science | en |
heal.journalType | peer reviewed | - |
heal.language | en | - |
heal.publicationDate | 2008 | - |
heal.publisher | European Peptide Society and John Wiley & Sons, Ltd. | en |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείας | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: